• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The role of the renin-angiotensin system in the control of cell communication in the heart: effects of enalapril and angiotensin II.

作者信息

De Mello W, Altieri P

机构信息

Department of Pharmacology, University of Puerto Rico, San Juan 00936-5067.

出版信息

J Cardiovasc Pharmacol. 1992 Oct;20(4):643-51. doi: 10.1097/00005344-199210000-00019.

DOI:10.1097/00005344-199210000-00019
PMID:1280722
Abstract

The influence of the renin-angiotensin system on the control of cell communication was investigated in isolated ventricular cell pairs of adult rats. It was found that angiotensin II (1 microgram/ml) reduced the junctional conductance (gj) by about 55% within 20 s. This effect of angiotensin II was suppressed by DuP 753--an angiotensin receptor blocking agent. Enalapril (1 microgram/ml)--an angiotensin converting enzyme inhibitor--caused an increase in junctional conductance (106%) within 2 min. The effect of enalapril on gj was not related to activation of beta-adrenergic receptors or cAMP-dependent protein kinase. The effect of angiotensin II on gj was suppressed by staurosporine--a potent inhibitor of protein kinase C. This finding indicates that the peptide is changing gj through activation of protein kinase C. The increase in cell coupling caused by enalapril raises the possibility that the antiarrhythmic action of enalapril as well its effect in congestive heart failure are related to an increase in electrical synchronization of cardiac myocytes.

摘要

相似文献

1
The role of the renin-angiotensin system in the control of cell communication in the heart: effects of enalapril and angiotensin II.
J Cardiovasc Pharmacol. 1992 Oct;20(4):643-51. doi: 10.1097/00005344-199210000-00019.
2
Renin-angiotensin system and cell communication in the failing heart.衰竭心脏中的肾素-血管紧张素系统与细胞通讯
Hypertension. 1996 Jun;27(6):1267-72. doi: 10.1161/01.hyp.27.6.1267.
3
Enalapril, an inhibitor of angiotensin converting enzyme, increases the junctional conductance in isolated heart cell pairs.依那普利,一种血管紧张素转换酶抑制剂,可增加离体心脏细胞对之间的连接电导。
J Cardiovasc Pharmacol. 1991 Oct;18(4):643-6. doi: 10.1097/00005344-199110000-00022.
4
Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
Am J Physiol. 1993 Nov;265(5 Pt 2):H1551-6. doi: 10.1152/ajpheart.1993.265.5.H1551.
5
Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
J Hypertens Suppl. 1993 Apr;11(3):S59-61.
6
Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.人前臂中血管紧张素转换酶抑制与血管紧张素II受体拮抗作用的比较。
J Cardiovasc Pharmacol. 1993 Oct;22(4):579-84. doi: 10.1097/00005344-199310000-00011.
7
Is an intracellular renin-angiotensin system involved in control of cell communication in heart?细胞内肾素-血管紧张素系统是否参与心脏细胞间通讯的调控?
J Cardiovasc Pharmacol. 1994 Apr;23(4):640-6. doi: 10.1097/00005344-199404000-00018.
8
Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?血管紧张素转换酶抑制的抗蛋白尿作用是通过干扰肾素-血管紧张素系统介导的吗?
Kidney Int. 1994 Mar;45(3):861-7. doi: 10.1038/ki.1994.113.
9
The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.肾素-血管紧张素系统与容量超负荷诱导的大鼠心肌肥厚。血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂的作用
Circulation. 1993 Mar;87(3):921-30. doi: 10.1161/01.cir.87.3.921.
10
Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.口服氯沙坦和依那普利对健康男性局部静脉及全身对血管紧张素I和II升压反应的不同影响。
Clin Pharmacol Ther. 1996 Jan;59(1):72-82. doi: 10.1016/S0009-9236(96)90026-0.

引用本文的文献

1
Reversing cardiac hypertrophy and heart failure using a cardiac targeting peptide linked to miRNA106a.使用与miRNA106a连接的心脏靶向肽逆转心脏肥大和心力衰竭
Clin Transl Med. 2025 Aug;15(8):e70432. doi: 10.1002/ctm2.70432.
2
COVID-19 and Cardiac Arrhythmias: Lesson Learned and Dilemmas.新冠病毒肺炎与心律失常:经验教训与困境
J Clin Med. 2024 Nov 29;13(23):7259. doi: 10.3390/jcm13237259.
3
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned?新冠病毒疫苗接种后心律失常:我们是否已彻底研究过所有问题?
Int J Mol Sci. 2023 Jun 20;24(12):10405. doi: 10.3390/ijms241210405.
4
Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.连接蛋白在心血管和神经血管健康与疾病中的作用:药理学意义
Pharmacol Rev. 2017 Oct;69(4):396-478. doi: 10.1124/pr.115.012062.
5
Phosphorylation of connexin in functional regulation of the cardiac gap junction.连接蛋白的磷酸化在心脏缝隙连接功能调节中的作用
Exp Clin Cardiol. 2004 Fall;9(3):161-4.
6
Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block.血管紧张素AT1受体转基因在小鼠心肌中的过表达产生了一种与心肌细胞增生和心脏传导阻滞相关的致死表型。
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6391-6. doi: 10.1073/pnas.94.12.6391.
7
A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study.
Naunyn Schmiedebergs Arch Pharmacol. 1994 Aug;350(2):174-84. doi: 10.1007/BF00241093.